Structure Based Design of Anti-Parkinson's Disease Compounds Targeting Synuclein Oligomerization
- 详细技术说明
- Recent work by UC San Diego investigators have focused on a specific region of alpha-synuclein critical to the aggregation process. Through the use of structure based design, peptidomimetic and peptide compounds were designed that block alpha-synuclein aggregation and neurodegeneration in an in-vitro model system. The initial compounds or their derivatives may serve as lead compounds or core structures that mimic natural chaperones that inhibit aggregation. This approach represents a radical shift from current approaches where reactive dyes are used in conjunction with the aggregated proteins to screen large chemical libraries, which may contain reactive compounds but potentially lack the required high degree of specificity to be a viable therapeutic candidate.
- *Abstract
-
Researchers at UC San Diego's School of Medicine have invented a nanostructured device with a significantly improved ZT figure of merit.
The pathogenesis of many neurodegenerative diseases (i.e., Parkinson’s disease and Lewy body dementia) is believed to involve the accumulation of alpha-synuclein, although how this buildup results in neuronal degeneration is still unclear. It has been shown that under pathological conditions, alpha-synuclein can aggregate into pentamers and hexamers that form pore-like structures. A better understanding of these oligomerization dynamics and subsequent fibril formation may lead to new avenues of treatment for Parkinson’s disease or other neurodegenerative diseases characterized by this type of aggregation phenomenon.
- *IP Issue Date
- May 28, 2013
- *Principal Investigation
-
Name: Eliezer Masliah
Department:
Name: Edward Rockenstein
Department:
Name: Igor Tsigelny
Department:
Name: Wolfgang Wrasidlo
Department:
- 申请号码
- 8450481
- 其他
-
Related Materials
Additional Technologies by these Inventors
- System for Tracking Sharps and Tools in the Operating Room
- Peptides Targeted to the CNS for Clearance of Protein Aggregates in Alzheimer's Disease
Tech ID/UC Case
19415/2007-274-0
Related Cases
2007-274-0
- 国家/地区
- 美国
欲了解更多信息，请点击 这里
